Ask AI
MATTERHORN
MATTERHORN: Phase III Trial of Durvalumab or Placebo + FLOT in Resectable Gastric and Gastroesophageal Junction Cancers

Released: June 05, 2025

Expiration: December 04, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 05, 2025

Expiration: December 04, 2025